82_FR_61555 82 FR 61308 - National Institute on Aging Notice of Closed Meeting

82 FR 61308 - National Institute on Aging Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 247 (December 27, 2017)

Page Range61308-61309
FR Document2017-27937

Federal Register, Volume 82 Issue 247 (Wednesday, December 27, 2017)
[Federal Register Volume 82, Number 247 (Wednesday, December 27, 2017)]
[Notices]
[Pages 61308-61309]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-27937]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Aging Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended. 
The grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Aging Special Emphasis 
Panel; Elder Mistreatment.
    Date: January 24, 2018.
    Time: 1:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute on Aging, Gateway Building, Suite 
2W200, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Kimberly Firth, Ph.D., National Institutes of 
Health, National Institute on Aging, Gateway Building, 7201 
Wisconsin Avenue, Suite 2C212, Bethesda, MD 20892, 301-402-7702, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging 
Research, National Institutes of Health, HHS)


[[Page 61309]]


    Dated: December 20, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-27937 Filed 12-26-17; 8:45 am]
 BILLING CODE 4140-01-P



                                               61308                           Federal Register / Vol. 82, No. 247 / Wednesday, December 27, 2017 / Notices

                                               78. Janice Espinosa, Dresher,                                            SUPPLEMENTARY INFORMATION:      Interested                        Prescription Drug, Improvement, and
                                                    Pennsylvania, Court of Federal                                      persons are invited to send comments                              Modernization Act (MMA) of 2003 (Pub.
                                                    Claims No: 17–1857V                                                 regarding this burden estimate or any                             L. 108–173) and became operational on
                                               [FR Doc. 2017–27961 Filed 12–26–17; 8:45 am]                             other aspect of this collection of                                July 1, 2005. The MMA legislation and
                                               BILLING CODE 4165–15–P
                                                                                                                        information, including any of the                                 implementing regulations issued on
                                                                                                                        following subjects: (1) The necessity and                         March 8, 2007 instituted a number of
                                                                                                                        utility of the proposed information                               changes in the appeals process. The
                                               DEPARTMENT OF HEALTH AND                                                 collection for the proper performance of                          MMA legislation also directed HHS to
                                               HUMAN SERVICES                                                           the agency’s functions; (2) the accuracy                          consider the feasibility of conducting
                                                                                                                        of the estimated burden; (3) ways to                              hearings using telephone or video-
                                               [Document Identifier OS–0990–0330]                                       enhance the quality, utility, and clarity                         teleconference (VTC) technologies. In
                                                                                                                        of the information to be collected; and                           carrying out this mandate, OMHA
                                               Agency Information Collection                                            (4) the use of automated collection
                                               Request. 30-Day Public Comment                                                                                                             makes use of both teleconferencing and
                                                                                                                        techniques or other forms of information                          VTC to provide appellants with a vast
                                               Request                                                                  technology to minimize the information                            nationwide network of access points for
                                               AGENCY:      Office of the Secretary, HHS.                               collection burden.                                                hearings close to their homes. The first
                                                                                                                          Title: Appellant Climate Survey,                                3-year administration cycle of the
                                               ACTION:      Notice.                                                     Revision.                                                         OMHA survey began in fiscal year (FY)
                                               SUMMARY:   In compliance with the                                          Abstract: The Office of Medicare
                                                                                                                                                                                          2008, a second 3-year cycle began in
                                               requirement of the Paperwork                                             Hearings and Appeals (OMHA) requests
                                                                                                                                                                                          FY2011, and third 3-year cycle began in
                                               Reduction Act of 1995, the Office of the                                 revision to a previously approved
                                                                                                                                                                                          FY2014. The survey will continue to be
                                               Secretary (OS), Department of Health                                     information collection request from the
                                                                                                                                                                                          conducted annually over a 3-year period
                                               and Human Services, is publishing the                                    Office of Management and Budget
                                                                                                                                                                                          with the next data collection cycle
                                               following summary of a proposed                                          (OMB). The annual OMHA Appellant
                                                                                                                        Climate Survey is a survey of Medicare                            beginning in FY2018. Data collection
                                               collection for public comment.                                                                                                             instruments and recruitment materials
                                                                                                                        beneficiaries, providers, suppliers, or
                                               DATES: Comments on the ICR must be
                                                                                                                        their representatives who participated                            will be offered in English and Spanish.
                                               received on or before January 26, 2018.                                  in a hearing before an Administrative                             Total burden for survey respondents is
                                               ADDRESSES: Submit your comments to                                       Law Judge (ALJ) from OMHA.                                        100.00 hours each year.
                                               OIRA_submission@omb.eop.gov or via                                       Appellants dissatisfied with the                                     Affected Public: Survey respondents
                                               facsimile to (202) 395–5806.                                             outcome of their Level 2 Medicare                                 will consist of Medicare beneficiaries
                                               FOR FURTHER INFORMATION CONTACT:                                         appeal may request a hearing before an                            and non-beneficiaries (i.e., providers,
                                               Sherrette Funn, Sherrette.Funn@hhs.gov                                   OMHA ALJ. The Appellant Climate                                   suppliers), who participated in a
                                               or (202) 795–7714. When submitting                                       Survey will be used to measure                                    hearing before an OMHA ALJ. OMHA
                                               comments or requesting information,                                      appellant satisfaction with their OMHA                            will draw a representative, non-
                                               please include the document identifier                                   appeals experience, as opposed to their                           redundant sample of appellants whose
                                               0990–New–30D and project title for                                       satisfaction with a specific ruling.                              cases have been closed in the last 6
                                               reference.                                                               OMHA was established by the Medicare                              months.

                                                                                                                TABLE 1—ESTIMATES OF RESPONDENT BURDEN
                                                                                                                                                                                          Number of         Burden per
                                                                                                                                                                        Number of                                         Total burden
                                                             Respondent type                                                 Form name                                                  responses per        response
                                                                                                                                                                       respondents                                          (hours)
                                                                                                                                                                                          respondent          (hours)

                                               Beneficiaries ......................................      Appellant Climate Survey .................                              200                 1            15/60          50.00
                                               Non-Beneficiaries ..............................          Appellant Climate Survey .................                              200                 1            15/60          50.00

                                                     Total ...........................................   ...........................................................             400                 1            15/60         100.00



                                               Terry S. Clark,                                                             The meeting will be closed to the                                Agenda: To review and evaluate grant
                                               Office of the Secretary, Asst. Paperwork                                 public in accordance with the                                     applications.
                                               Reduction Act Reports Clearance Officer.                                 provisions set forth in section                                     Place: National Institute on Aging,
                                               [FR Doc. 2017–27857 Filed 12–26–17; 8:45 am]                             552b(c)(6), Title 5 U.S.C., as amended.                           Gateway Building, Suite 2W200, 7201
                                               BILLING CODE 4150–46–P                                                   The grant applications and the                                    Wisconsin Avenue, Bethesda, MD 20892
                                                                                                                        discussions could disclose confidential                           (Telephone Conference Call).
                                                                                                                        trade secrets or commercial property                                Contact Person: Kimberly Firth, Ph.D.,
                                               DEPARTMENT OF HEALTH AND                                                 such as patentable material, and                                  National Institutes of Health, National
                                               HUMAN SERVICES                                                                                                                             Institute on Aging, Gateway Building, 7201
                                                                                                                        personal information concerning
                                                                                                                                                                                          Wisconsin Avenue, Suite 2C212, Bethesda,
                                                                                                                        individuals associated with the grant
                                               National Institutes of Health                                                                                                              MD 20892, 301–402–7702, firthkm@
                                                                                                                        applications, the disclosure of which
                                                                                                                                                                                          mail.nih.gov.
daltland on DSKBBV9HB2PROD with NOTICES




                                               National Institute on Aging Notice of                                    would constitute a clearly unwarranted
                                                                                                                        invasion of personal privacy.                                     (Catalogue of Federal Domestic Assistance
                                               Closed Meeting                                                                                                                             Program Nos. 93.866, Aging Research,
                                                                                                                         Name of Committee: National Institute on                         National Institutes of Health, HHS)
                                                 Pursuant to section 10(d) of the                                       Aging Special Emphasis Panel; Elder
                                               Federal Advisory Committee Act, as                                       Mistreatment.
                                               amended, notice is hereby given of the                                    Date: January 24, 2018.
                                               following meeting.                                                        Time: 1:30 p.m. to 4:30 p.m.



                                          VerDate Sep<11>2014        21:43 Dec 26, 2017        Jkt 244001       PO 00000        Frm 00058        Fmt 4703        Sfmt 4703   E:\FR\FM\27DEN1.SGM   27DEN1


                                                                        Federal Register / Vol. 82, No. 247 / Wednesday, December 27, 2017 / Notices                                             61309

                                                 Dated: December 20, 2017.                               Name of Committee: National Cancer                    Date: February 28–March 1, 2018.
                                               Melanie J. Pantoja,                                     Institute Special Emphasis Panel; TEP–6:                Time: 5:00 p.m. to 5:00 p.m.
                                                                                                       Modified RNA and Oncosomes.                             Agenda: To review and evaluate contract
                                               Program Analyst, Office of Federal Advisory
                                                                                                         Date: February 14, 2018.                            proposals.
                                               Committee Policy.
                                                                                                         Time: 9:00 a.m. to 6:00 p.m.                          Place: Hilton Washington DC/Rockville
                                               [FR Doc. 2017–27937 Filed 12–26–17; 8:45 am]              Agenda: To review and evaluate contract             Hotel, 1750 Rockville Pike, Bethesda, MD
                                               BILLING CODE 4140–01–P                                  proposals.                                            20852.
                                                                                                         Place: National Cancer Institute, Shady               Contact Person: Nadeem Khan, Ph.D.,
                                                                                                       Grove, 9609 Medical Center Drive, Room                Scientific Review Officer, Research
                                               DEPARTMENT OF HEALTH AND                                7W114, Rockville, MD 20850 (Telephone                 Technology and Contract Review Branch,
                                               HUMAN SERVICES                                          Conference Call).                                     Division of Extramural Activities, National
                                                                                                         Contact Person: Jeffrey E. DeClue, Ph.D.,           Cancer Institute, NIH 9609 Medical Center
                                               National Institutes of Health                           Scientific Review Officer, Research                   Drive, Room 7W260, Bethesda, MD 20892–
                                                                                                       Technology and Contract Review Branch,                9750, 240–276–5856, nadeem.khan@nih.gov.
                                               National Cancer Institute; Notice of                    Division of Extramural Activities, National             Name of Committee: National Cancer
                                                                                                       Cancer Institute, NIH, 9609 Medical Center            Institute Special Emphasis Panel; SEP–1 for
                                               Closed Meetings
                                                                                                       Drive, Room 7W114, Bethesda, MD 20892–                Provocative Questions.
                                                                                                       9750, 240–276–6371, decluej@mail.nih.gov.               Date: March 1, 2018.
                                                  Pursuant to section 10(d) of the
                                                                                                         Name of Committee: National Cancer                    Time: 8:00 a.m. to 5:00 p.m.
                                               Federal Advisory Committee Act, as
                                                                                                       Institute Special Emphasis Panel; NCI                   Agenda: To review and evaluate grant
                                               amended, notice is hereby given of the                  Program Project I.                                    applications.
                                               following meetings.                                       Date: February 20–21, 2018.                           Place: Gaithersburg Marriott
                                                  The meetings will be closed to the                     Time: 4:00 p.m. to 5:00 p.m.                        Washingtonian Center, 9751 Washingtonian
                                               public in accordance with the                             Agenda: To review and evaluate grant                Boulevard, Gaithersburg, MD 20878.
                                               provisions set forth in sections                        applications.                                           Contact Person: Byeong-Chel Lee, Ph.D.,
                                                                                                         Place: Gaithersburg Marriott                        Scientific Review Officer, Resources and
                                               552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                       Washingtonian Center, 9751 Washingtonian              Training Review Branch, Division of
                                               as amended. The grant and/or contract                   Boulevard, Gaithersburg, MD 20878.                    Extramural Activities, National Cancer
                                               proposals applications and the                            Contact Person: Klaus B. Piontek, Ph.D.,            Institute, NIH 9609, Medical Center Drive,
                                               discussions could disclose confidential                 Scientific Review Officer, Research Program           Room 7W238, Bethesda, MD 20892–9750,
                                               trade secrets or commercial property                    Review Branch, Division of Extramural                 240–276–7755, byeong-chel.lee@nih.gov.
                                               such as patentable material, and                        Activities, National Cancer Institute, NIH,             Name of Committee: National Cancer
                                               personal information concerning                         9609 Medical Center Drive, Room 7W612,                Institute Special Emphasis Panel, NCI
                                               individuals associated with the grant                   Bethesda, MD 20892–9750, 240–276–5413.                Clinical and Translational Exploratory/
                                               and/or contract proposals applications,                 klaus.piontek@nih.gov.                                Developmental Studies.
                                               the disclosure of which would                             Name of Committee: National Cancer                    Date: March 1–2, 2018.
                                               constitute a clearly unwarranted                        Institute Special Emphasis Panel; Imaging               Time: 5:00 p.m. to 5:00 p.m.
                                                                                                       Radiation and Immunotherapies.                          Agenda: To review and evaluate grant
                                               invasion of personal privacy.
                                                                                                         Date: February 20–21, 2018.                         applications.
                                                  Name of Committee: National Cancer                     Time: 6:00 p.m. to 5:00 p.m.                          Place: Bethesda North Marriott Hotel &
                                               Institute Special Emphasis Panel; NCI SPORE               Agenda: To review and evaluate contract             Conference Center, 5701 Marinelli Road,
                                               II Review.                                              proposals.                                            North Bethesda, MD 20852.
                                                  Date: January 29–30, 2018.                             Place: Bethesda North Marriott Hotel &                Contact Person: Zhiqiang Zou, MD, Ph.D.,
                                                  Time: 4:00 p.m. to 5:00 p.m.                         Conference Center, 5701 Marinelli Road,               Scientific Review Officer, Special Review
                                                  Agenda: To review and evaluate grant                 North Bethesda, MD 20852.                             Branch, Division of Extramural Activities,
                                               applications.                                             Contact Person: Jun Fang, Ph.D., Scientific         National Cancer Institute, NIH, 9609 Medical
                                                  Place: Bethesda North Marriott Hotel &               Review Officer, Research Technology and               Center Drive, Room 7W242, Bethesda, MD
                                               Conference Center, 5701 Marinelli Road,                 Contract Review Branch, Division of                   20892–9750, 240–276–6372, zouzhiq@
                                               Bethesda, MD 20852.                                     Extramural Activities, National Cancer                mail.nih.gov.
                                                  Contact Person: Klaus B. Piontek, Ph.D.,             Institute, NIH, 9609 Medical Center Drive,              Name of Committee: National Cancer
                                               Scientific Review Officer, Research Program             Room 7W246, Bethesda, MD 20892–9750,                  Institute Special Emphasis Panel; NCI R03 &
                                               Review Branch, Division of Extramural                   240–276–5460, jfang@mail.nih.gov.                     Clinical and Translational R21: SEP–1A.
                                               Activities, National Cancer Institute, NIH,               Name of Committee: National Cancer                    Date: March 29, 2018.
                                               9609 Medical Center Drive, Room 7W612,                  Institute Special Emphasis Panel; Biological            Time: 11:00 a.m. to 4:00 p.m.
                                               Bethesda, MD 20892–9750, 240–276–5413,                  Comparisons in Patient-Derived Models of                Agenda: To review and evaluate grant
                                               klaus.piontek@nih.gov.                                  Cancer.                                               applications.
                                                  Name of Committee: National Cancer                     Date: February 23, 2018.                              Place: National Cancer Institute, Shady
                                               Institute Special Emphasis Panel; Cancer                  Time: 1:00 p.m. to 4:00 p.m.                        Grove, 9609 Medical Center Drive, Room
                                               Cachexia Therapy and Local Delivery of                    Agenda: To review and evaluate grant                7W260, Rockville, MD 20850 (Telephone
                                               Chemopreventive Agents.                                 applications.                                         Conference Call).
                                                  Date: February 8, 2018.                                Place: National Cancer Institute, Shady               Contact Person: Nadeem Khan, Ph.D.,
                                                  Time: 9:00 a.m. to 4:00 p.m.                         Grove, 9609 Medical Center Drive, Room                Scientific Review Officer, Research
                                                  Agenda: To review and evaluate contract              7W236, Rockville, MD 20850 (Telephone                 Technology and Contract Review Branch,
                                               proposals.                                              Conference Call).                                     Division of Extramural Activities National,
                                                  Place: National Cancer Institute, Shady                Contact Person: Robert S. Coyne, Ph.D.,             Cancer Institute, NIH, 9609 Medical Center
                                               Grove, 9609 Medical Center Drive, Room                  Scientific Review Officer, Special Review             Drive, Room 7W260, Bethesda, MD 20892–
                                               7W030, Rockville, MD 20850 (Telephone                   Branch, Division of Extramural Activities,            9750, 240–276–5856, nadeem.khan@nih.gov.
daltland on DSKBBV9HB2PROD with NOTICES




                                               Conference Call).                                       National Cancer Institute, NIH, 9609 Medical          (Catalogue of Federal Domestic Assistance
                                                  Contact Person: Jun Fang, Ph.D., Scientific          Center Drive, Room 7W236, Bethesda, MD                Program Nos. 93.392, Cancer Construction;
                                               Review Officer, Research Technology and                 20892–9750, 240–276–5120, coynes@                     93.393, Cancer Cause and Prevention
                                               Contract Review Branch, Division of                     mail.nih.gov.                                         Research; 93.394, Cancer Detection and
                                               Extramural Activities, National Cancer                    Name of Committee: National Cancer                  Diagnosis Research; 93.395, Cancer
                                               Institute, NIH, 9609 Medical Center Drive,              Institute Special Emphasis Panel; TEP–2:              Treatment Research; 93.396, Cancer Biology
                                               Room 7W246, Bethesda, MD 20892–9750,                    Software Tools & Sensors for the Cancer               Research; 93.397, Cancer Centers Support;
                                               240–276–5460, jfang@mail.nih.gov.                       Therapeutics.                                         93.398, Cancer Research Manpower; 93.399,



                                          VerDate Sep<11>2014   21:43 Dec 26, 2017   Jkt 244001   PO 00000   Frm 00059   Fmt 4703   Sfmt 4703   E:\FR\FM\27DEN1.SGM   27DEN1



Document Created: 2017-12-27 02:23:11
Document Modified: 2017-12-27 02:23:11
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesJanuary 24, 2018.
FR Citation82 FR 61308 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR